VOA
•78% Informative
Medicines and Healthcare Regulator thousands says it approved the treatment for sickle cel U.K. sease and thalas Thursday o are Medicines old a Healthcare Regulatory Agency rrow transplants, Casgevy ly ard first procedures that come with unpleasant side effec CRISPR ve been the only long-las Nobel treatment. 2020 an class="summaryFeed_highLightText__NxlGi">Indian 12 years old le Eastern Casgevy Vertex Pharmaceuticals Text__NxlGi">Africa CRISPR Therapeutics ss="summaryFeed_highLightText__NxlGi">India Africa U.S. CRISPR ghtText__NxlGi">about 100,000 Helen O'Neill yFee University College London illions Britain Medicines MHRA maryFeed_highLightText__NxlGi">$1.7 million up to about $1.6 million age 65 earlier this year African d_hi Caribbean xt__NxlGi">around $2 million Institute for Clinical and Economic Review Vertex U.S. every few weeks n Vertex Pharmaceuticals South Asian ee Southeast Asian __Nxl Middle Eastern ealth Service Casgevy ummaryFeed_highLightText__NxlGi">England $3.5 million first xt__NxlGi">£2.8 million Britain Last year millions of dollars at least a year 42 39 at least one yearJames LaBelle ass="summaryFeed_highLightText__NxlGi">28 the University of Chicago ">29Britain n class="summaryFeed_highL U.S. Text__NxlGi">Britain Casgevy maryFeed_highLightText__NxlGi">t the U.S. Food and Drug Administration n class="summaryFeed_highLightText__NxlGi">L early next month
VR Score
89
Informative language
95
Neutral language
55
Article tone
formal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links